Skip to content

Effect of anesthesia on abdominal wall during video surgery in patients undergoing intestinal resection: a double-blind, randomized clinical study

Analgesic effect of laparoscopic-guided transversus abdominis plane block (TAP block) in laparoscopic colorectal surgery: a randomized, double-blinded trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-9j49xsg
Enrollment
Unknown
Registered
2024-09-06
Start date
2021-08-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopy

Interventions

The masking will be of the "triple-blind" type. Experimental group: 15 patients will undergo TAP block using a ropivacaine solution. Control group: 15 patients will undergo TAP block using a saline so
and 10 mL of solution (2) one centimeter below the costal margin, at the anterior axillary line (total volume 40mL). This procedure will be performed by the surgeon at the beginning of the surgical pr

Sponsors

Hospital Governador Israel Pinheiro
Lead Sponsor
Hospital Felício Rocho
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteers with an indication for segmental colon resection; aged 18 years or older; elective surgical proposal; laparoscopic surgery proposal; both sexes

Exclusion criteria

Exclusion criteria: Volunteers with pre-anesthetic assessment ASA IV-V; a history of allergic reactions to local anesthetics; complaints of chronic pain, chronic opioid use, or opioid tolerance; the need for resection of organs other than the colon, rectum, and/or cecal appendix; preoperative signs of intestinal obstruction; surgical indication for laparotomy access; signs of inflammation or infection at the TAP block puncture sites; surgeries for the treatment of neoplastic recurrence

Design outcomes

Primary

MeasureTime frame
Reduction in the level of pain at rest, measured on a 0 to 10 Visual Analog Scale 24 hours after the procedure, by at least 1 point between the intervention and control groups

Secondary

MeasureTime frame
Reduction in the level of resting pain, measured from 0 to 10 on the Visual Analog Scale 48 hours post-procedure, by at least 1 point between the intervention and control groups; reduction in cough-induced pain, measured from 0 to 10 on the Visual Analog Scale 24 and 48 hours post-procedure, by at least 1 point between the intervention and control groups;Incidence of postoperative nausea and vomiting, measured at 24 and 48 hours post-procedure on a 1 to 4-point scale, where 1: absence of nausea and vomiting, 2: nausea only without vomiting, 3: a single episode of vomiting but persistent nausea, and 4: two or more episodes of vomiting, with an average reduction of at least 1 point in the intervention group;Difference in time to initiate diet, measured in hours after the end of the surgical procedure, with a reduction of at least 6 hours in the intervention group;Onset of ambulation, measured in hours after the end of the surgical procedure, with a reduction of at least 6 hours in the intervention group;Opioid use, measured by the total sum of all opioids used in morphine milligram equivalents in the first 24 hours, with a reduction of at least 20% in the intervention group;Total surgery time, measured in minutes, with no difference between the groups;Total length of hospital stay, measured in days and hours, with a reduction of at least 1 day in the intervention group

Countries

Brazil

Contacts

Public ContactAlan Araújo

Hospital Governador Israel Pinheiro

alanacfa@hotmail.com+5531991240843

Outcome results

None listed

Source: REBEC (via WHO ICTRP)